- Home
- FGEN
FGEN
FibroGen Inc
as 11-14-2024 1:32pm EST
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 34.0M | IPO Year: | 2014 |
| Target Price: | N/A | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.18 - $2.93 | Next Earning Date: | 11-12-2024 |
| Revenue: | $180,015,000 | Revenue Growth: | 16.15% |
| Revenue Growth (this year): | 20.42% | Revenue Growth (next year): | -14.13% |
Latest FibroGen Inc News
FGEN Breaking Stock News: Dive into FGEN Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
2 days ago
Q3 2024 FibroGen Inc Earnings Call
GuruFocus.com
2 days ago
FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions
Zacks
2 days ago
FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates
Associated Press Finance
2 days ago
FibroGen: Q3 Earnings Snapshot
GlobeNewswire
2 days ago
FibroGen Reports Third Quarter 2024 Financial Results
GlobeNewswire
10 days ago
FibroGen to Report Third Quarter 2024 Financial Results
GuruFocus.com
a month ago
FibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts
Clinical Trials Arena
2 months ago
Duchenne muscular dystrophy: major trials and events to watch in 2023
Compare FGEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FGEN FibroGen Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.